Within Major Pharmaceutical Preparations industry China Health Industries Holdings Inc booked the highest Quick Ratio than China Health Industries Holdings Inc in the third quarter 2024. While total ranking remained the same in the Q3 2024 compared to the second quarter 2023 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents CHHE�s has?
What are CHHE�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CHHE Quick Ratio	(Mar 31 2024) Q3	(Dec 31 2023) Q2	(Sep 30 2023) Q1	(Jun 30 2023) Q4	(Mar 31 2023) Q3
Y / Y Current Liabilities Change	-0.85 %	0.8 %	-22.82 %	-24.82 %	-30.71 %
Y / Y Cash & cash equivalent Change	-	-99.96 %	-99.97 %	-99.89 %	-8.59 %
Quick Ratio MRQ	-	0	0	0.01	6.58
CHHE's Total Ranking	#	#	#	#	#
Seq. Current Liabilities Change	-0.39 %	9.97 %	-0.2 %	-9.31 %	1.27 %
Seq. Cash & cash equivalent Change	-	23.06 %	-73.61 %	-99.89 %	0.39 %

Quick Ratio third quarter 2024 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Quick Ratio Statistics
High	Average	Low
0	0	0

Financial Statements
China Health Industries Holdings Inc 's Current Liabilities	$ 7 Millions	Visit CHHE's Balance sheet
China Health Industries Holdings Inc 's Cash & cash equivalent	$ 0 Millions	Visit CHHE's Balance sheet
Source of CHHE's Sales		Visit CHHE's Sales by Geography

Cumulative China Health Industries Holdings Inc 's Quick Ratio

CHHE's Quick Ratio for the trailling 12 Months

CHHE Quick Ratio	(Mar 31 2024) 12 Months	(Dec 31 2023) 12 Months	(Sep 30 2023) 12 Months	(Jun 30 2023) 12 Months	(Mar 31 2023) 12 Months
Y / Y Current Liabilities TTM Growth	-13 %	-20.84 %	-27.29 %	-24.44 %	-21.46 %
Y / Y Cash & cash equivalent TTM Growth	-99.96 %	-75.54 %	-52.28 %	-30.52 %	-6.14 %
Quick Ratio TTM	0	1.73	3.46	4.8	6.03
Total Ranking TTM	# 4292	# 3579	# 2897	# 3353	# 2526
Seq. Current Liabilities TTM Growth	-0.22 %	0.21 %	-6.58 %	-6.86 %	-9.21 %
Seq. Cash & cash equivalent TTM Growth	-99.83 %	-49.85 %	-32.72 %	-25.8 %	-2.29 %

Quick ratio ranking by company, industry and sector >> Back to CHHE Financial Strength Comparisons >> Go to Compare CHHE Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in CHHE's Current Liabilities to $6.53 millions, cumulative Quick Ratio to 0 below the CHHE average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 528 other companies have achieved higher Quick Ratio than China Health Industries Holdings Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 3579 to 4292.

Explain Quick Ratio?
How much Cash & cash equivalents CHHE�s has?
What are CHHE�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 529
Healthcare Sector	# 1083
Within the Market	# 4292

trailing twelve months Quick Ratio Statistics
High	Average	Low
7.12	4.63	0
(June 30. 2014)		(Mar 31 2024)

Companies with similar Quick Ratio in the quarter ending Mar 31 2024, within Major Pharmaceutical Preparations Industry

Quick Ratio

Mar 31 2024 MRQ Cash & cash equivalent

Mar 31 2024 MRQ Current Liabilities

Date modified: 2026-09-08T15:11:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.